Received Aug 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
the patient was supposed to get meningococcal group A but instead got meningococcal group B (Bexsero); This non-serious case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 13-year-old female patient who received Men B NVS (Bexsero) for prophylaxis. Co-suspect products included Meningococcal vaccine A for prophylaxis. On an unknown date, the patient received Bexsero and did not receive Meningococcal vaccine A. On an unknown date, an unknown time after receiving Bexsero, the patient experienced wrong vaccine administered (Verbatim: the patient was supposed to get meningococcal group A but instead got meningococcal group B (Bexsero)). The outcome of the wrong vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 23-JUL-2025 The reporter reported that the patient received Bexsero vaccine for meningococcal, the patient was supposed to get meningococcal group A but instead got meningococcal group B, which led to wrong vaccine administered.